This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Usability Metric for User eXperience (UMUX-Lite)
Timeframe: Immediately, after 1-month of testing - objective 2
Acceptability E-Scale (AES)
Timeframe: Immediately after 1-month of testing - objective 2
Change in Acceptability E-Scale (AES) over 12 months
Timeframe: Once every 3 months within 12 months
Change in Intervention Appropriateness Measure (IAM) over 12 months
Timeframe: Once every 3 months within 12 months
Change in Compatibility Subscale over 12 months
Timeframe: Once every 3 months within 12 months